Human OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity.
about
Pharmacogenomics in Pediatric Patients: Towards Personalized MedicineAn integrated view of cisplatin-induced nephrotoxicity and ototoxicityPlatinum-induced ototoxicity: a review of prevailing ototoxicity criteria.Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin.Role of transporters in the distribution of platinum-based drugs.Pharmacotherapeutic options for treating adverse effects of Cisplatin chemotherapy.The role of germline variants in chemotherapy outcome in brain tumors: a systematic review of pharmacogenetic studies.Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics.The Role of Transporters in the Toxicity of Chemotherapeutic Drugs: Focus on Transporters for Organic Cations.Impact of Transporter Polymorphisms on Drug Development: Is It Clinically Significant?Organic Cation Transporter 2 (OCT2/SLC22A2) Gene Variation in the South African Bantu-Speaking Population and Functional Promoter Variants.Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin.Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity.Hydrogen Inhalation Protects against Ototoxicity Induced by Intravenous Cisplatin in the Guinea Pig.Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies.Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection.Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.Systematic review of pharmacogenomics and adverse drug reactions in paediatric oncology patients.Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer.Interaction of the New Monofunctional Anticancer Agent Phenanthriplatin With Transporters for Organic Cations.
P2860
Q28071448-43D5FFE9-0A2B-421C-AB47-84519017E7BDQ28080615-9F3DF5A6-817C-4AB4-A753-31AA4DFBDF8CQ36035287-9AD74D0F-05C5-4531-B5B1-71F701617119Q36412220-CD7C850B-D5E7-476B-97EC-3F5116302FBDQ38474594-642E1311-C757-431E-A12F-C242661AE60BQ38637751-7344DF05-A042-4E1A-A02A-400F0DB49D32Q38739253-01F7F371-C752-47BA-A58B-48600378FF96Q38851414-242B0590-3B1F-4F2B-84B1-FF3E3CD9BC63Q38888345-E0AC49E6-C7A1-4554-8989-7F7F1A3A6714Q38888369-F9E8A8D8-9ABB-4FD3-8B9D-33A953961D14Q38933341-E2D0350E-1BEC-45E8-9F25-427D460358B9Q40600080-803B773C-BF95-4DEF-B46D-2E04E8C8C8E3Q41369087-1B899476-5783-4FF1-885E-0A5BF4068343Q41683998-45025587-3EB2-4670-B6BB-AB6B350459B4Q42361422-8B71CCE4-D869-4BE1-8895-EF94546BC9E6Q46256727-ED0BC75A-C1E4-40BF-AC39-23EE1BC0BB31Q47819341-6EFEA8C0-0A59-44DC-9850-AE63BFF3459BQ48331843-DBEAD93A-1507-4EFF-8FA6-5B15E115F23EQ50313675-BCAC8F22-AA30-410C-9B34-41FF25EEB71FQ50346981-1FD91F55-07C7-4BF6-BFDB-532FE179BCE5Q55449228-184C7D37-EEA7-42C0-AF72-8648E7DDEFF8
P2860
Human OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Human OCT2 variant c.808G>T co ...... cisplatin-induced ototoxicity
@nl
Human OCT2 variant c.808G>T co ...... cisplatin-induced ototoxicity.
@ast
Human OCT2 variant c.808G>T co ...... cisplatin-induced ototoxicity.
@en
type
label
Human OCT2 variant c.808G>T co ...... cisplatin-induced ototoxicity
@nl
Human OCT2 variant c.808G>T co ...... cisplatin-induced ototoxicity.
@ast
Human OCT2 variant c.808G>T co ...... cisplatin-induced ototoxicity.
@en
prefLabel
Human OCT2 variant c.808G>T co ...... cisplatin-induced ototoxicity
@nl
Human OCT2 variant c.808G>T co ...... cisplatin-induced ototoxicity.
@ast
Human OCT2 variant c.808G>T co ...... cisplatin-induced ototoxicity.
@en
P2093
P2860
P50
P3181
P356
P1433
P1476
Human OCT2 variant c.808G>T co ...... cisplatin-induced ototoxicity.
@en
P2093
Antionette G Am Zehnhoff-Dinnesen
Ingrid Malath
Jason A Sprowl
Joachim Boos
Ron Hj Mathijssen
P2860
P304
P3181
P356
10.2217/PGS.14.182
P407
P50
P577
2015-01-01T00:00:00Z